Track topics on Twitter Track topics that are important to you
Modernizing certain laws and regulations to support the move to value-drive health care is an important step in moving our health care system forward. As part of PhRMA’s proactive policy solutions, we’ve recommended modernizing of the Anti-Kickback Statute to support expanded value-based contracting between biopharmaceutical companies and private payers or health care providers.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...